PARP1 inhibition by Olaparib reduces the lethality of pancreatic cancer cells and increases their sensitivity to Gemcitabine
- Quiñonero, F.
- Mesas, C.
- Muñoz-Gámez, J.A.
- Jiménez-Luna, C.
- Perazzoli, G.
- Prados, J.
- Melguizo, C.
- Ortiz, R.
Revue:
Biomedicine and Pharmacotherapy
ISSN: 1950-6007, 0753-3322
Année de publication: 2022
Volumen: 155
Type: Article
